Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Garbage. Almost no volume. Nothing for shareholders. 22k in volume isn't heavy it's pathetic. But, it's the first day in a while ANY shares were traded. A new all time low when the RS is factored in.
I LOVE the ignore feature. My life just improved dramatically.
Exactly
You have consistently been wrong about the long term direction and potential of this company. Short term SP projections mean nothing.
Well, you're wrong. The pipeline is diverse with huge market impact. This is setting up exactly as we want it for a buy or several license agreements. Anyone who can't see how fast this company is moving toward a breakout is looking backward. Turn around, sport.
I'm confident that the pipeline is full of transformational therapies and That Lander is looking to create shareholder value now; in part because he and Kood are biggest shareholders.
Worthless shares. Zero volume no sales, no products.
Another massive day of trading
My guess is that Rgbpp will soon rise faster than Rgbp but both have turned a corner and will rise on continued good news.
Wrong. But who cares about this POS.
No, it's down over 90 pct. all know 1/150 share R/S impact.
No one's buying misleading information. Those who own are stuck in an empty shell headed for delisting.
A few still support and believe. I'm reminded of the remote island bound Japanese soldiers who didn't know the war had ended 10 years earlier.
Wonder if Lander is going?
Huge progress in a very short time. The list is impressive. As far as financing, between their recent uplist PR and Schuller's post describing his conversations with them it's clear. Sell some shares at market, enough to advance or complete a number of of their initiatives so that they have much more leverage before entering into a license or sale arrangement with Big Pharma. If advances are exciting enough their share sales will be into a rising market and we should see diminimus dilution. Sounds like a smart, investor friendly strategy to me but I'm certain you'll find doom and gloom. The good news is neither of us can predict the future. My opinion is based on strong progress this year as reported by the company and first hand communications between the company and shareholders, your's appears to be conspiracy nutcase logic.
FDA approval of Hema IND, collaberation with NIH and Eli Lilly, submission and IND number for tCell, program for NF2 universal doner platform, Hema expansion based on lives saved at Pan Am cancer center, upgrade to OTCQB. All happened in last 5 months. It's clear as a bell, no BS, nothing hidden in those lines. Only those whose bitterness tries to make up facts that support their anger can't see the progress.
BS. MDIN, if they ever decide to post another Q will show a huge increase in share count representing dilution at its worst.
Blindness to progress is the issue here. I see it. You refuse to.
I have noticed.
I am always happy at the progress made against cancer and rare diseases. And , I'm firmly confident I'll make a lot of money here and day is not too far off. I'll take my enthusiasm over bitter gloom and negativism every day.
ANAS cooked. No update coming. It's an empty shell.
ANAS is an empty shell after reverse split. All products and assets turned over to MDIN, another failed Barton SCAM. The BS numbers posted don't take into account the 1 for 150 reverse split that occurred in August last year. GLTU. You'll need it.
Another delivered promise by Regen. I'm very happy with this. RGBPP up 20 pct.
Is it disturbing to you that the SP is now going up on good volume?
Future looks bright. Big product pipeline. Falsely claiming Hema rejection by FDA; now that's fraud.
Not worth the time to expose their failures anymore. Everyone knows. One or two may say "get ready" but that's just a cruel joke now.
Agreed. Too many fronts where great progress is possible.
Finished even, sport.
Thanks. The science is life changing. SP was kl catch up.
Great future. Only the bitter and blind can't see it. GREAT time to buy.
Someone bought every share, sport.Green Day.
From the SV X files. That's where Hema rejection came from and other completely false conspiracies, actions and plots. 4 folks in a cancer center are very relieved this company is here. Many thousands will soon be joining the ranks. When Uplist occurs and some of the many outstanding Science work starts to hit the presses, this flies.
Save your advice. Your DD came up with Hema IND being rejected when it was approved by the FDA. That was FACTUALLY 100 pct wrong. Go RGBP.
Decent start to the week. Come on Lander hit us with Eli Lilly news this week.
Who cares where it's sold. No one is buying.
The science is ground breaking and the number of people who will be helped by the five areas of preclinical and clinical trial work is breathtaking. Eli Lilly and the NIH are involved. The breadcrumbs of clues as to how they're going to create huge value for shareholders and, yes, themselves are pretty clear. It's currently being ignored because 1) it's on the OTC pinks and 2) its credibility and universal attention will come only with acknowledgement from BP and/or the NIH in a major announcement.
By the way the FDA states they try and approve New IND applications in 11 to 12 months but that many new drug applications may take much longer. Ignoring the science here is no less backward and unhelpful as laughing at the concept of a round world in 1492 but GLTU. Don't fall off the edge of the earth.
Huge News. ucVax. Also, tCell now has an IND number.
UcVax.
HUGE NEWS. unVax will be a game changer and the PR even noted tCell now has an IND number.
There is so much activity still to be updated and expected for this Q. ODD, Dcell, Tcell IND number, Hema amendment for treatment of post chemo white blood cell production, NCI update, Eli Lilly collaberation, 4th IND application as well as new updates on the Pan Am study. I believe we hear about all of this very soon and as Lander predicts great value will be created for shareholders. Everyone can make their own decisions but I'm holding for what I believe will be a huge increase in SP.